What is Rigel Pharmaceuticals's R&D?

Rigel Pharmaceuticals (RIGL) reported R&D of $11.68M in Q1 2026.

How has Rigel Pharmaceuticals's R&D changed year-over-year?

Rigel Pharmaceuticals's R&D increased by 38.4% year-over-year, from $8.44M to $11.68M.

What is the long-term trend for Rigel Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Rigel Pharmaceuticals's R&D has grown at a -15.5% compound annual growth rate (CAGR), from $65.24M to $33.3M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Rigel Pharmaceuticals RIGL R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

Agios PharmaceuticalsAGIO

$81.15M+11.6%

Nuvation BioNUVB

$35.05M+42.5%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

Gyre Therapeutics, Inc.GYRE

$6.74M+118%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's R&D?: Rigel Pharmaceuticals (RIGL) reported R&D of $11.68M in Q1 2026.
How has Rigel Pharmaceuticals's R&D changed year-over-year?: Rigel Pharmaceuticals's R&D increased by 38.4% year-over-year, from $8.44M to $11.68M.
What is the long-term trend for Rigel Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Rigel Pharmaceuticals's R&D has grown at a -15.5% compound annual growth rate (CAGR), from $65.24M to $33.3M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.